Conference Description
The 11th Annual Stroke Conference presented by UF Health Shands Hospital & UF Health Jacksonville will take place on April 6, 2024 in Orlando, FL! This CME program is designed to improve the knowledge, competence and performance of healthcare providers engaged in the care of patients with cerebrovascular diseases. The goal of the program is to reduce the gap between current evidence and existing practice in stroke care as well as review the most recent clinical trials that impact patient care algorithms and practices. This conference will focus on science, technology and practical applications in order to equip participants with the tools needed to deliver high quality, evidence-based, patient centered stroke care. Speakers include internationally recognized stroke experts offering specialized topics that cover stroke care across the continuum.
Target Audience
This program is intended for adult neurologists, neurosurgeons, neurointerventionalists, neuroradiologists, interventional radiologists, emergency medicine specialists, primary care physicians, nurses, nurse practitioners, physician assistants, rehabilitation specialists, physical, occupational and speech therapists, respiratory therapists, radiology technologists, case managers, social workers, pharmacists and researchers in the field of cerebrovascular function and disease.
Learning Objectives
Upon conclusion of this program, participants should be able to:
- Identify best practices for the acute phase of care in stroke patients
- Identify stroke and treatment options
- Identify late breaking updates to the care of the stroke patient population
Faculty Disclosure
University of Florida College of Medicine adheres to the ACCME Standards regarding commercial support of continuing medical education. It is policy that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this education activity, that relevant conflicts of interest are resolved, and that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made in the course syllabus.
Check out this clip from our 2017 Stroke Conference! Dr. Brian Hoh, MD discusses Endovascular Therapy: The New Frontier: